Liquid Chromatographic Analysis of Carbonyl Compounds in Aerosols from High and Low Nicotine E-Cigarette Liquids Mirroring Realistic Puffing Topography.

Slides:



Advertisements
Similar presentations
Evaluation of the skycig electronic cigarette for nicotine delivery and subjective effects following acute use in regular users Lynne Dawkins 1 & Olivia.
Advertisements

E-cigarettes: Craving, Quitting & Addictive Potential - keeping up with a rapidly evolving phenomena Dr. Lynne Dawkins Drugs and Addictive Behaviours Research.
Should Medical Providers Recommend E-cigarettes to their Patients as a Smoking Cessation Tool? There is not yet enough Evidence to Recommend EC as a Primary.
Poster 3-41, Society for Research on Nicotine & Tobacco, Apr 29, 2009, Dublin Potential Toxicity of Hand-rolled and Factory-made Cigarette Smoking Compared.
The Novice User’s Experience of the Titan 510 Electronic Cigarette: a Mixed Methods Approach Victoria Lawson, Sharon Cahill & Lynne Dawkins School of Psychology,
Chapter 20: The Effects of Tobacco Use. Key Terms  Nicotine  Stimulant  Carcinogen  Tar  Carbon Monoxide  Smokeless Tobacco  Leukoplakia  Nicotine.
Tobacco Lesson 1. Tobacco has ____________ effects on almost all body systems. cigarette lungs cancer tobacco harmful crave oxygen.
First vs. Second Generation E- Cigarettes: Predictors of choice and effects on tobacco craving and withdrawal symptoms Dr. Lynne Dawkins Drugs and Addictive.
Next steps for the regulation of cigarettes Bill King and Ron Borland.
ADDITIONAL TESTS Ignition Propensity Testing Toxicity Assays.
Information on tobacco packages could encourage and help tobacco users to stop using tobacco or find least possible harmful ways of use for those unable.
Vaping profiles and preferences: an online survey of electronic cigarette users Dawkins, L., Turner, J. Roberts, A. & Soar, K. Drugs & Addictive Behaviours.
Tobacco 101:. Why are cigarettes bad for your health? Cigarettes have over 7,000 chemicals other than nicotine. Chemicals such as acetone (nail polish.
Unit 21 More on Smoking
Electronic Cigarettes: What we know so far
Chebatoris, A.W., Harvey, J.W., Hess, B.T., Krepps, J.P., O’Brien, K.A., Short, D.B., and Spaulding, R.E. Figure 1: ACH apparatus: CO detector, cigar and.
1 Questions to the Subcommittee 1.What criteria do you recommend to TPSAC for selecting the initial list of H/PH constituents?
Our Global Harm Reduction Programme TMA 2009 David O’Reilly, PhD Head of Public Health & Scientific Affairs © British-American Tobacco (Holdings) Limited.
Chapter 9 Rejecting Tobacco Use.
Do Electronic Cigarettes Correlate with Cancer?
Materials & Methods Introduction Results Kelly Steffen R.N., Sara Aragon, Pat Bloecher, Matt Sisbach, Faculty Sponsors: Crispin Pierce & Kathy German-Olson.
 2007 Johns Hopkins Bloomberg School of Public Health Tobacco Control Surveillance Benjamin Apelberg, PhD, MHS Institute for Global Tobacco Control Johns.
Norwich Medical School Faculty of Medicine and Health Science Longer-Term Smoking Abstinence after treatment by specialist or non-specialist advisors:
Can undergoing an internet based ACT intervention change the impact of predictors thought to lead to Substance Use? Leonidou. G., Savvides. S., N. & Karekla.
STANDARD HE7.7: Practice health-enhancing behaviors and avoid or reduce health risk. (c) Demonstrate behaviors to avoid or reduce health risks to self.
Maternal Smoking and Infant Birth Weight Lucinda England, MD, MSPH National Institute of Child Health and Human Development (NICHD)
FDA Regulation of Tobacco Washington, DC October 21, 2015 What is Relative Risk-a look at the Continuum of Harm Aruni Bhatnagar, PhD, Professor, University.
NICOTINE and the BRAIN Wilson M. Compton, MD, MPE Deputy Director, U.S. National Institute on Drug Abuse.
Ch. 20 A. Leslie. The health effects of tobacco smoke affect smokers and nonsmokers alike. Nonsmokers who breathe air containing tobacco smoke are also.
0 1 Cigarettes mg 11mg 55mg 110 mg Cigarette Smoking Impacts.
Joyce Alexander Azusa Pacific University GNRS 507.
CHAPTER 21 TOBACCO MRS. CRUSAN HOME LIVING. ADDICTIVE DRUG A SUBSTANCE THAT CAUSES PHYSIOLOGICAL OR PSYCHOLOGICAL DEPENDENCE. ONE REASON IT IS SO DIFFICULT.
Potential Reduced Exposure Products for Tobacco Users: What Do We Need to Know, What Do We Know, and How do We Get There From Here? Thomas Eissenberg,
By: Sherry Hargrove Core: 1 Science. I decided to do my project on tobacco smoke and the chemicals found in it. Also I wanted to tell of the harms tobacco.
The association between European Medicines Agency approval and Health Technology Assessment recommendations Iga Lipska 1,2, Anke Hövels 2, Neil McAuslane.
Tobacco Use in Mental Health Settings Alternative Nicotine Devices and Products Materials Prepared By: Center for a Tobacco Free Finger Lakes University.
Caroline O. Cobb, Ph.D. VCU Psychology Department & Center for the Study of Tobacco Products Vaping & Students: Who’s Puffing What?
Strategies for regulation of cigarette emissions The WHO product regulatory approach Nigel Gray David Burns For TobReg Working Group 1 in Conjunction with.
E - CIGARETTES: WHAT’S THE REAL MEDICAL INNOVATION BREAKTHROUGH? Dr Kevin Bridgman - Chief Medical Officer & Director Nicovations is a wholly owned subsidiary.
West Sussex Stop Smoking Service E-Cig Friendly Rebecca Robb and Caroline Staddon, Smokefree West Sussex.
INVESTIGATION TASK CIGARETTE CHANGES BY JESS M AND JESS D NO SMOKING PAST THIS POINT!!!!!
Addressing Tobacco Use in Mental Health Settings Alternative Nicotine Delivery Devices and Products Materials Prepared By: Center for a Tobacco-Free Finger.
EXPOSURE TO TOBACCO SMOKE IN THE EUROPEAN UNION 2nd Working Meeting on Adult Premature Mortality in the European Union October 2006, Warsaw, Poland.
Self-titration by experienced e- cigarette users: Blood nicotine delivery and subjective effects Lynne Dawkins (LSBU), Catherine Kimber (UEL), Mira Doig.
Electronic Cigarettes a summary of the current evidence Hayden McRobbie Clinical Director – The Dragon Institute for Innovation Professor of Public Health.
Regulation of: - amounts of various constituents in cigarette smoke - information on packages regarding smoke constituents - smokefree tobacco products.
Thomas Bell and Andy Cooper 3M Drug Delivery Systems Ltd, Loughborough, Leicestershire, LE11 1EP 3M Drug Delivery Systems Monitoring of Droplet Size Changes.
Vapeboss.co.nz. E-cigarettes or Electronic cigarettes are electronic appliances that that try to evoke the sensation of tobacco smoking. These E cigarettes.
PRACTICAL PROBLEMS OF COMPARATOR SELECTION TO ASSESS COSTEFFECTIVENESS OF NEW DRUGS FOR REIMBURSEMENT DECISION: A QUALITATIVE STUDY IN SOUTH KOREA Hye-Young.
Trends in electronic cigarette use in England
Attitudes Towards E-Cigarette Online Advertising: A Pilot Study
The NIDA Standardized Research E-Cigarette (SREC) and its Evaluation in Risk Reduction and Related Studies (PAR ) Kevin Walton, Aidan Hampson Division.
Overview of NPN Session
Quick facts about E-cigarettes for mental health and addiction clinicians and administrators Associate Professor of Psychiatry,
Waterpipes Use among High School Students in Jakarta
Roommate Closeness Development and Pathological Personality Traits
Vasanthi Bathrinarayanan, P.1
SETTING THE QUALITY AND SAFETY STANDARDS FOR NOVEL TOBACCO PRODUCTS
Assessing E-cigarette cytotoxicity using two in-vitro methodologies
Descriptive e-cigarette norms on tobacco attitudes and smoking behavior: The importance of close friends and peers Michael Coleman & William D. Crano.
“Stop Calling It Vapor!”
Tobacco Review.
Dawkins, L., Turner, J. Roberts, A. & Soar, K.
Electronic Nicotine Delivery Systems
Session 1: Consequences of E-Cigarette Use
A.M. CLARKE-CORNWELL1, P.A. COOK1 and M.H.GRANAT1
The NIDA Standardized Research E-Cigarette (SREC)
Trends in electronic cigarette use in England
Chaney et al.’s funhaler study (2004)
Presentation transcript:

Liquid Chromatographic Analysis of Carbonyl Compounds in Aerosols from High and Low Nicotine E-Cigarette Liquids Mirroring Realistic Puffing Topography Kimber CF1, Kośmider L2, Kurek J2, Corcoran O3, Dawkins LE4 c.kimber@uel.ac.uk leon.kosmider@gmail.com 1) Drugs and Addictive Behaviours Research Group, School of Psychology, University of East London, Water lane, Stratford, London, E15 4LZ, UK ; 2) Institute of Occupational Medicine and Environmental Health, Poland; 3) The Medicines Research Group, School of Health, Sport and Bioscience, University of East London, Stratford campus; 4) Division of Psychology, School of Applied Sciences, 103 Borough Road, London South Bank University, London, SE1 0AA, UK Introduction Results Tobacco smokers engage in more intensive puffing regimes (more frequent and longer puffs) when switching from higher to lower nicotine-containing cigarettes [1,2,3,4], this can result in increased toxicant exposure [5]. Such compensatory puffing behaviour has recently been demonstrated in experienced vapers using high and low nicotine concentration liquids in the lab [6]. Although exposure to toxins in e-cigarette aerosols is negligible by comparison with tobacco smoke [7], whether a more intensive puffing regime associated with using a lower nicotine concentration liquid increases exposure, has not been explored. This research is particularly timely with the recent introduction (20th May 2016) of the European Tobacco Product Directive (EU-TPD). In the liquid, there was no statistical difference between conditions for levels of acetaldehyde (p = 0.41). Levels of formaldehyde, acetone and acrolein were either not detected (N.D) or below the limit of quantification (BLQ). In the aerosols, based on participants’ puffing topography, levels detected were as follows for: formaldehyde 3.41 ±0.94 vs 1.49 ±0.30, acetaldehyde 2.17 ±0.36 vs 1.04 ±0.13 and acetone 0.73 ±0.20 vs 0.28 ±0.14 (all p < 0.01) in the 6 and 24 mg/mL nicotine concentration liquids respectively. Acrolein was not detected (figure 3). Table 2. Levels of carbonyl compounds found in liquids Levels (µg/50µl) in Liquids Formaldehyde Acetaldehyde Acetone Acrolein 6 mg/mL N.D 0.059 – 0.075 BLQ 24 mg/mL 0.043 – 0.067 0.080 – 0.094 Aims To establish whether more intensive puffing regimes associated with using a lower nicotine concentration produces higher levels of toxicants from e-cigarette nicotine aerosols. Table 3. Levels of carbonyl compounds found in aerosols Levels (µg) in Aerosols Formaldehyde Acetaldehyde Acetone Acrolein 6 mg/mL 3.058 - 4.966 2.119 - 2.736 0.434 - 0.979 N.D 24 mg/mL 0.950 - 1.770 0.831 - 1.143 0.158 - 0.553 Methodology HPLC/diode array analysis was employed. Four carbonyl compounds formaldehyde, acetaldehyde, acrolein and acetone were quantified in liquid (vehicle of propylene glycol and vegetable glycerine 50/50%) and aerosol using 24 mg/mL and 6 mg/mL nicotine concentration liquids. Aerosols were generated by a smoking machine (figure 2; University of Technology, Lodz, Poland [8]) configured to exactly replicate puffing topography data obtained from a sample of 12 experienced vapers using both aforementioned solutions, for 1 h [6]. The ‘Joyetech eVic Supreme’ e-cigarette (figure 1) (output voltage 3.9) was mounted with the Aspire Nautilus BVC tank (atomiser 1.8 Ohm). The 6 mg/mL liquid was used more intensively compared to the 24 mg/mL. Results are presented in number of puffs taken on average for 1 h of e-cigarette use (74 and 47 for 6 and 24 mg/mL liquids respectively as per the puffing topography in Dawkins et al, in press; table 1). Analyses was performed 6 times for each solution. T-tests were used for comparing the means in aerosols and in solutions. Figure 2. Smoking machine Figure 3. Levels of toxicants detected in aerosols Table 1. Puffing protocol used in the study * P < 0.01; whiskers - SEM Puff duration Number of puffs Intervals between puffs Sampling time 24 mg/mL 3.76s. 14 74.5s. 1017s. 6 mg/mL 5.04s. 44.3s. 641s. Conclusions The smoking machine, programmed with a more intensive puffing regimen to reflect compensation by experienced vapers on lower nicotine concentration liquid, resulted in higher aerosol levels of formaldehyde, acetaldehyde and acetone. Our findings suggest, vapers making a sudden switch to much lower nicotine concentration liquid (either due to the EU-TPD implementation or personal choice) may inadvertently increase their exposure to carbonyl compounds through compensatory puffing behaviour. Figure 1. E-cigarette and tank used in the study References Ashton H, Stepney R, Thompson JW. Self-titration by cigarette smokers. Br Med J. 1979 Aug 11;2(6186):357-60. Hasenfratz M, Baldinger B, Bättig K. Nicotine or tar titration in cigarette smoking behavior?. Psychopharmacology. 1993 Sep 1;112(2-3):253-8. Herning RI, Jones RT, Bachman J, Mines AH. Puff volume increases when low-nicotine cigarettes are smoked. Br Med J (Clin Res Ed). 1981 Jul 18;283(6285):187-9. Russell MA, Jarvis M, Iyer R, Feyerabend C. Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br Med J. 1980 Apr 5;280(6219):972-6. Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug and alcohol dependence. 2007 Jan 12;86(2):294-300.. Dawkins, L., Kimber, C., Doig, M., Feyerabend., C., Corcoran, O. (in press) Self-Titration by Experienced E-cigarette Users: Blood Nicotine Delivery and Subjective Effects. Psychopharmacology. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, Prokopowicz A, Jablonska-Czapla M, Rosik-Dulewska C, Havel C, Jacob P. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tobacco control. 2014 Mar 1;23(2):133-9. Goniewicz ML, Kuma T, Gawron M, Knysak J, Kosmider L. Nicotine levels in electronic cigarettes. Nicotine & Tobacco Research. 2012 Apr 22:nts103. Competing interests No financial support from any companies was received for this work and there are no non-financial conflicts of interest that would be considered relevant to this work. CFK, LK and JK declare no competing interests. LED and OC have previously conducted research for several independent electronic cigarette companies. These companies had no input into the design, conduct or write up of the projects. LED has also acted as a consultant for the pharmaceutical industry and as an expert witness in a patent infringement case. www.uel.ac.uk/psychology